Lindbrook Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 29,632 shares of VRTX stock, worth $14.9 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

29,632

Previous 21,760 36.18%

Holding current value

$14.9 Million

Previous $10.2 Million 35.12%

% of portfolio

1.16%

Previous 0.97%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$460.0 - $505.78 $3.62 Million - $3.98 Million	7,872 Added 36.18%	29,632 $13.8 Million
Q2 2024 Jul 31, 2024	SELL	$392.81 - $485.53 $3.31 Million - $4.09 Million	-8,428 Reduced 27.92%	21,760 $10.2 Million
Q1 2024 Apr 25, 2024	BUY	$407.69 - $446.08 $7.74 Million - $8.47 Million	18,996 Added 169.73%	30,188 $12.6 Million
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $1.77 Million - $2.12 Million	5,161 Added 85.57%	11,192 $4.55 Million
Q3 2023 Oct 25, 2023	SELL	$338.18 - $362.46 $1.81 Million - $1.94 Million	-5,345 Reduced 46.98%	6,031 $2.1 Million
Q2 2023 Jul 28, 2023	SELL	$314.42 - $351.91 $6.42 Million - $7.18 Million	-20,406 Reduced 64.21%	11,376 $4 Million
Q1 2023 Apr 26, 2023	SELL	$283.23 - $323.1 $44,467 - $50,726	-157 Reduced 0.49%	31,782 $10 Million
Q4 2022 Jan 24, 2023	BUY	$285.76 - $321.48 $6.91 Million - $7.78 Million	24,198 Added 312.6%	31,939 $0
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $878,446 - $980,140	3,208 Added 70.77%	7,741 $2.24 Million
Q2 2022 Aug 01, 2022	BUY	$234.96 - $292.55 $413,999 - $515,473	1,762 Added 63.59%	4,533 $1.28 Million
Q1 2022 Apr 21, 2022	BUY	$221.42 - $260.97 $387,263 - $456,436	1,749 Added 171.14%	2,771 $723,000
Q4 2021 Jan 18, 2022	BUY	$177.01 - $223.45 $94,877 - $119,769	536 Added 110.29%	1,022 $224,000
Q3 2021 Nov 05, 2021	SELL	$181.39 - $202.99 $4,171 - $4,668	-23 Reduced 4.52%	486 $88,000
Q2 2021 Jul 27, 2021	SELL	$187.49 - $221.1 $2,624 - $3,095	-14 Reduced 2.68%	509 $103,000
Q1 2021 Apr 28, 2021	BUY	$207.02 - $241.31 $2,277 - $2,654	11 Added 2.15%	523 $112,000
Q4 2020 Jan 27, 2021	SELL	$207.01 - $276.09 $9,522 - $12,700	-46 Reduced 8.24%	512 $121,000
Q3 2020 Nov 03, 2020	BUY	$255.65 - $303.1 $16,361 - $19,398	64 Added 12.96%	558 $152,000
Q2 2020 Jul 27, 2020	SELL	$225.48 - $295.8 $1,803 - $2,366	-8 Reduced 1.59%	494 $143,000
Q1 2020 Apr 22, 2020	SELL	$199.77 - $247.81 $32,762 - $40,640	-164 Reduced 24.62%	502 $119,000
Q4 2019 Jan 27, 2020	SELL	$166.71 - $223.91 $10,836 - $14,554	-65 Reduced 8.89%	666 $146,000
Q3 2019 Oct 31, 2019	SELL	$166.23 - $187.09 $2,493 - $2,806	-15 Reduced 2.01%	731 $124,000
Q2 2019 Jul 24, 2019	BUY	$164.61 - $190.37 $2,798 - $3,236	17 Added 2.33%	746 $136,000
Q4 2018 Feb 07, 2019	BUY	$151.91 - $192.21 $110,742 - $140,121	729 New	729 $120,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Vertex Pharmaceuticals Inc Transaction History